Rheumatology
Partner With Us
Advertisement
Cancer

Transforming Treatment for Chronic Lymphocytic Leukemia Patients

Over the past 10 years, the treatment landscape and prognosis for Chronic Lymphocytic Leukemia (CLL) has dramatically improved, even among older adults.

Fox Chase Cancer Center
Over the past 10 years, the treatment landscape and prognosis for Chronic Lymphocytic Leukemia (CLL) has dramatically improved, even among older adults. In this video, Shazia Nakhoda, MD, Assistant Professor, Department of Hematology/Oncology, Fox Chase Cancer Center, discusses the latest best practices for diagnosing, treating and managing CLL, providing internists with a comprehensive overview of optimal therapies, cardiac risk and hypertension assessment, routine cancer screening and CDC vaccination guidelines and multidisciplinary, collaborative care. Topics include: Work up and diagnosis of unexplained persistent lymphocytosis Current preferred latest treatments Venetoclax with Obinutuzumab and CLL prognosis Multidisciplinary care to manage toxicity, recurrent infections, cytopenia, and secondary cancers Guidance on CDC-recommended vaccinations and infection prevention